Xtant Medical Holdings, Inc. XTNT

What this company does

Xtant Medical Holdings, Inc. designs, develops and commercializes orthobiologics and spinal implant fixation systems used to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar and interbody spine. It promotes its products in the United States through independent distributors and stocking agents, supported by direct employees. It also promotes and sells its products internationally through stocking distribution partners in Europe, Canada, Mexico, South America and certain Pacific region countries. Its spinal implant product line treats a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor, including through minimally invasive surgery techniques. As of December 31, 2025, it had 151 full-time employees, of whom 64 were in operations, 28 in sales and marketing, 12 in research and development and engineering, 24 in regulatory and quality affairs, and 23 in administrative functions. The company began operations in 1998 as a spin out of the Center for Biofilm Engineering at Montana State University and incorporated as “Bacterin, Inc.” in the state of Montana in January 2000.

Written from the business description in Xtant Medical Holdings, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 31 March 2026. Every sentence was checked against that document before publication.